2019 Hepatitis B and C Annual Surveillance Report

2019 Hepatitis B and C Annual Surveillance Report

2019 Hepatitis B and C Annual Surveillance Report Viral Hepatitis Surveillance and Prevention Unit Updated October 22, 2020 Table of Contents Viral Hepatitis Data Summary ............................................................................................................................................................................... 3 Background and Technical Notes ........................................................................................................................................................................... 7 Michigan Census and Demographics .....................................................................................................................................................................11 Population by Age, Sex & Education .......................................................................................................................................................................... 12 Population by Race & Ethnicity .................................................................................................................................................................................. 13 Poverty, Income & Health Insurance ......................................................................................................................................................................... 14 Acute Hepatitis B ..................................................................................................................................................................................................16 Acute Hepatitis B—Incidence and Sex ....................................................................................................................................................................... 17 Acute Hepatitis B—Race and Ethnicity ...................................................................................................................................................................... 18 Acute Hepatitis B—Risk Behaviors ............................................................................................................................................................................. 19 Acute Hepatitis B Rate Maps by County and Local Health Jurisdiction ...................................................................................................................... 20 Chronic Hepatitis B ...............................................................................................................................................................................................21 Chronic Hepatitis B—Incidence and Sex .................................................................................................................................................................... 22 Chronic Hepatitis B—Race and Ethnicity ................................................................................................................................................................... 23 Chronic Hepatitis B Rate Maps by County and Local Health Jurisdiction ................................................................................................................... 25 Acute Hepatitis C ..................................................................................................................................................................................................26 Acute Hepatitis C—Incidence and Sex ....................................................................................................................................................................... 27 Acute Hepatitis C—Race and Ethnicity ...................................................................................................................................................................... 28 Acute Hepatitis C Rate Maps by County and Local Health Jurisdiction ...................................................................................................................... 30 Chronic Hepatitis C ...............................................................................................................................................................................................31 Chronic Hepatitis C—Incidence and Sex .................................................................................................................................................................... 32 Chronic Hepatitis C—Race and Ethnicity ................................................................................................................................................................... 33 Chronic Hepatitis C—Risk Behaviors .......................................................................................................................................................................... 34 Chronic Hepatitis C Rate Maps by County and Local Health Jurisdiction ................................................................................................................... 35 Hepatitis C Testing & Treatment ...........................................................................................................................................................................36 Hepatitis C—Testing and Genotype Data .................................................................................................................................................................. 37 Viral Hepatitis Medicaid Data .................................................................................................................................................................................... 39 MDHHS Bureau of Laboratories Hepatitis C Testing .................................................................................................................................................. 40 Focus Populations ................................................................................................................................................................................................43 Adults Under Forty (18-39 years of age) .................................................................................................................................................................... 44 Adults Under Forty (18-39 years old) HCV Case Rate Maps by County and Local Health Jurisdiction ....................................................................... 47 Drug Poisoning and Drug Treatment Data ................................................................................................................................................................. 48 Emergency Department Syndromic Surveillance Data .............................................................................................................................................. 49 Total Drug Poisoning Death Rate Maps by County and Local Health Jurisdiction ..................................................................................................... 51 Opioid Overdose Death Rate Maps by County and Local Health Jurisdiction ............................................................................................................ 52 Heroin Overdose Death Rate Maps by County and Local Health Jurisdiction ........................................................................................................... 53 Treatment Episode Data Sets (TEDS) Rate Maps by County and Local Health Jurisdiction ....................................................................................... 54 Neonatal Abstinence Syndrome (NAS) ...................................................................................................................................................................... 55 Perinatal Hepatitis C .................................................................................................................................................................................................. 56 Perinatal Hepatitis B .................................................................................................................................................................................................. 58 Hepatitis and HIV Co-infections ................................................................................................................................................................................. 60 Hepatitis C and HIV Co-infections Among MIDAP Beneficiaries ................................................................................................................................ 63 Viral Hepatitis Outcomes ......................................................................................................................................................................................64 Viral Hepatitis Hospitalizations and Liver Transplants ............................................................................................................................................... 65 Viral Hepatitis-Related Cancer & Mortality ............................................................................................................................................................... 66 Hepatitis C Emerging Threats Project ........................................................................................................................................................................ 69 Harm Reduction and Syringe Service Programs ....................................................................................................................................................70

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    79 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us